Ionova, T., Andrievskikh, M., Amdiev, A., Baryakh, E., Chang, V., Endakova, A., Fadeeva, N., Husainova, G., Ivanov, V., Kaplanov, K., Kaverina, O., Kiseleva, M., Klitochenko, T., Kurakin, V., Larionova, O., Lazareva, D., Lepik, K., Lysenko, I., Melnichenko, V., Mikhailova, N., Minullina, R., Mironov, O., Misyurina, E., Mochkin, N., Nikitina, T., Osipov, Y., Petrova, T., Porfirieva, N., Rukavitsyn, O., Safin, R., Samoylova, A., Shelekhova, T., Sherstnev, D., Simashova, P., Smirnova, E., Trenina, N., Vasiliev, E., & Volodicheva, E. (n.d.). bRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE. Hematological oncology, 39, n/a. http://access.bl.uk/ark:/81055/vdc_100133622671.0x000037